Univest
Univest
  • Markets

Buzzing Stocks Today: Dr Reddy’s Up 4% Despite USFDA Observations; Persistent Slips 10% on Nagarro Acquisition

  • June 29, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
Buzzing Stocks Today

Buzzing today: DRREDDY +4.17% (Rs 1,406.80) – USFDA 7 Form 483 obs. PERSISTENT -10.45% (Rs 4,335.50) – Nagarro EUR 81/share, 140% premium, EUR 1.4 Bn bridge financing.

Two contrasting stories define the buzzing stocks today list: Dr Reddy’s Laboratories is hitting a new 52-week high, gaining 4.17% to Rs 1,406.80, even as the USFDA issued a Form 483 with seven observations at its Bachupally biologics facility. At the other extreme, Persistent Systems is the session’s top midcap loser, crashing 10.45% to Rs 4,335.50, after announcing over the weekend that it plans to acquire German digital engineering firm Nagarro SE at EUR 81 per share through its subsidiary Galaxy Germany Holding SE. Both announcements landed during the three-day Muharram holiday gap and are being fully priced in today for the first time.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Dr Reddy’s: Buzzing Stock Up 4% – USFDA Form 483 Not a Deterrent
  • Persistent Systems: Buzzing Stock Down 10% – Nagarro Deal Spooks Investors
  • Conclusion: Buzzing Stocks Today
  • Frequently Asked Questions
    • Why is Dr Reddy’s a top buzzing stock today?
    • Why is Persistent Systems the biggest buzzing stock loser today?
    • What does Form 483 mean for Dr Reddy’s?
    • Who is Nagarro SE and why is Persistent acquiring it?
    • Which other stocks are buzzing today besides Dr Reddy’s and Persistent?
    • Where can I track buzzing stocks today?

Dr Reddy’s: Buzzing Stock Up 4% – USFDA Form 483 Not a Deterrent

Dr Reddy’s is one of the most actively tracked buzzing stocks today, gaining 4.17% to a new 52-week high of Rs 1,414.90 on volumes crossing 4 million shares. The USFDA completed a Pre-License Inspection at the company’s Bachupally biologics facility between June 16-25, issuing Form 483 with seven observations. Investors are treating this as a routine regulatory interaction: a Form 483 is not a Warning Letter, does not prohibit product sales, and companies are given a standard timeline to submit corrective action plans. The company has committed to addressing all observations within the stipulated timeframe. The Nifty Pharma index is the top sector today at +1.73%, providing strong sectoral momentum to Dr Reddy’s. Nomura maintains a Buy with target price Rs 1,740.

Dr Reddy’s Metric Value
DRREDDY CMP Rs 1,406.80 (+4.17%)
52W High (New) Rs 1,414.90 (set today)
Session Volume 4 million+ shares
USFDA Action Form 483, 7 observations – Bachupally biologics PLI
Nifty Pharma 25,402 (+1.73%) – top sector
Nomura Target Rs 1,740 (Buy)

Research Both Buzzing Stocks on Univest Screener

Persistent Systems: Buzzing Stock Down 10% – Nagarro Deal Spooks Investors

Persistent Systems is the most significant negative buzzing stock today and the top midcap loser. The company’s subsidiary Galaxy Germany Holding SE (BidCo) has made a voluntary public tender offer to acquire all Nagarro SE shares at EUR 81 per share in cash. The offer implies approximately 140% premium to Nagarro’s June 25 closing price and about 94% to the three-month VWAP. Persistent already holds approximately 21% of Nagarro. The deal is funded partly through EUR 1.4 billion in bridge financing and targets a combined revenue run-rate of $2.9 billion with over 46,000 employees across 40-plus countries. Closing is targeted for Q4 2026 or Q1 2027.

Brokerages find the acquisition expensive. CLSA (outperform, TP Rs 6,520) has cut FY27-28 EPS by 6-7%, noting Persistent’s $2 billion revenue milestone will arrive only by Q4 FY27, later than expected. Nomura (neutral, TP Rs 5,200) cut FY27-28 EPS by 2-4% after a modest revenue and margin miss in Q4. The EUR 1.4 billion bridge financing burden is the primary investor concern.

Persistent Metric Value
PERSISTENT CMP Rs 4,335.50 (-10.45%, -Rs 506.00)
Previous Close Rs 4,841.50
Intraday Low Rs 4,312.00
52W High / Low Rs 6,599 / Rs 4,449.10
Nagarro Offer Price EUR 81/share (~140% premium)
Bridge Financing EUR 1.4 billion
CLSA Target (cut) Rs 6,520 (EPS cut 6-7%)
Nomura Target (cut) Rs 5,200 (EPS cut 2-4%)

Download the Univest iOS App or Univest Android App to track all buzzing stocks today live with research on Univest.

Conclusion: Buzzing Stocks Today

The buzzing stocks today narrative is a tale of two sectors: pharma is in a breakout while IT faces an acquisition-driven sell-off. Dr Reddy’s is setting new annual highs with institutional volume support, while Persistent Systems is approaching its 52-week low on acquisition premium concerns. Investors should evaluate each stock individually on fundamentals and risk profile and consult a SEBI-registered financial advisor before making any investment decisions.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why is Dr Reddy’s a top buzzing stock today?

Ans. Dr Reddy’s is a top buzzing stock today, gaining 4.17% to a new 52-week high of Rs 1,414.90. Despite the USFDA issuing Form 483 with 7 observations at its Bachupally biologics facility, investors are treating it as a routine regulatory event. Nifty Pharma sector is up 1.73%, volumes are elevated above 4 million shares and Nomura maintains Buy with target Rs 1,740.

Why is Persistent Systems the biggest buzzing stock loser today?

Ans. Persistent Systems is falling 10.45% to Rs 4,335, making it the biggest midcap loser among buzzing stocks today. The company announced acquisition of Nagarro SE at EUR 81/share (140% premium) through a subsidiary, with EUR 1.4 billion in bridge financing. Brokerages CLSA and Nomura have cut EPS estimates by 2-7%, finding the acquisition expensive.

What does Form 483 mean for Dr Reddy’s?

Ans. Form 483 is an initial USFDA communication issued after an inspection identifies potential GMP deviations. It is not a Warning Letter or Import Alert and does not block existing product sales. Companies typically have 15 business days to submit a corrective action plan. Dr Reddy’s has committed to address all 7 observations at its Bachupally biologics facility within the stipulated timeline.

Who is Nagarro SE and why is Persistent acquiring it?

Ans. Nagarro SE is a Germany-listed digital engineering company with expertise in Manufacturing, Retail and Public Services verticals, plus SAP and CX capabilities. Persistent Systems aims to create an AI-led digital engineering powerhouse with $2.9 billion in combined revenue run-rate and 46,000+ employees. The deal diversifies Persistent’s revenue beyond North America into Europe and the Middle East.

Which other stocks are buzzing today besides Dr Reddy’s and Persistent?

Ans. Other buzzing stocks today include Kotak Mahindra Bank (-2.49%, CEO succession news), HDFC Bank (+0.59%, legal review cleared governance concerns), Transrail Lighting (+0.72%, Rs 459 crore MENA T&D orders), Astral (-7.75%, Q4 margin miss), Trent (+2.70%) and Cipla (+2.49%). Nifty Pharma is the top sector and Nifty IT is the weakest sector today.

Where can I track buzzing stocks today?

Ans. You can track buzzing stocks today live using the Univest Screener, which provides real-time NSE and BSE prices, volume data, 52-week highs and lows, brokerage targets and sector performance. The screener allows filtering by sector, price movement and volume to identify both positive and negative buzzing stocks across the market.



Buzzing Stocks Today
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply